Source: Business Wire

Press Release: BioSkryb : BioSkryb Genomics to Highlight Power of Next Generation Single-Cell Technology at AGBT 2024

DURHAM, N.C.--(BUSINESS WIRE)--BioSkryb to introduce new products and present novel applications of industry-leading portfolio at AGBT 2024.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Suresh Pisharody's photo - CEO of BioSkryb

CEO

Suresh Pisharody

CEO Approval Rating

82/100

Read more